Annual EBITDA
-$168.00 M
-$93.80 M-126.42%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual EBITDA is -$168.00 million, with the most recent change of -$93.80 million (-126.42%) on December 31, 2022.
- During the last 3 years, KDNY annual EBITDA has fallen by -$121.73 million (-263.12%).
Performance
KDNY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$68.47 M
-$8.88 M-14.91%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly EBITDA is -$68.47 million, with the most recent change of -$8.88 million (-14.91%) on June 30, 2023.
- Over the past year, KDNY quarterly EBITDA has dropped by -$31.07 million (-83.06%).
Performance
KDNY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$228.09 M
-$31.07 M-15.77%
June 30, 2023
Summary
- As of February 10, 2025, KDNY TTM EBITDA is -$228.09 million, with the most recent change of -$31.07 million (-15.77%) on June 30, 2023.
- Over the past year, KDNY TTM EBITDA has dropped by -$149.79 million (-191.31%).
Performance
KDNY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KDNY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -126.4% | -83.1% | -191.3% |
| 3 y3 years | -263.1% | -792.5% | -1261.0% |
| 5 y5 years | -263.1% | -259.4% | -4368.1% |
KDNY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +126.4% | at low | -453.2% | at low | +222.8% | at low |
| 5 y | 5-year | +263.1% | at low | -453.2% | at low | +4368.1% | at low |
| alltime | all time | +263.1% | at low | -453.2% | at low | +4368.1% | at low |
Chinook Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$68.47 M(+14.9%) | -$228.09 M(+15.8%) |
| Mar 2023 | - | -$59.59 M(+16.0%) | -$197.03 M(+17.3%) |
| Dec 2022 | -$168.00 M(+126.4%) | -$51.37 M(+5.5%) | -$168.00 M(+72.8%) |
| Sep 2022 | - | -$48.67 M(+30.1%) | -$97.24 M(+24.2%) |
| Jun 2022 | - | -$37.40 M(+22.4%) | -$78.30 M(+10.8%) |
| Mar 2022 | - | -$30.56 M(-257.6%) | -$70.67 M(-4.8%) |
| Dec 2021 | -$74.20 M | $19.39 M(-165.2%) | -$74.20 M(-40.6%) |
| Sep 2021 | - | -$29.73 M(-0.2%) | -$124.82 M(+18.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$29.77 M(-12.7%) | -$105.48 M(+26.5%) |
| Mar 2021 | - | -$34.09 M(+9.1%) | -$83.38 M(+56.5%) |
| Dec 2020 | -$53.28 M(+15.2%) | -$31.24 M(+200.8%) | -$53.28 M(+558.4%) |
| Sep 2020 | - | -$10.39 M(+35.4%) | -$8.09 M(-51.7%) |
| Jun 2020 | - | -$7.67 M(+92.7%) | -$16.76 M(+84.4%) |
| Mar 2020 | - | -$3.98 M(-128.5%) | -$9.09 M(+78.0%) |
| Dec 2019 | -$46.27 M | $13.95 M(-173.2%) | -$5.11 M(-73.2%) |
| Sep 2019 | - | -$19.05 M | -$19.05 M |
FAQ
- What is Chinook Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Chinook Therapeutics?
- What is Chinook Therapeutics annual EBITDA year-on-year change?
- What is Chinook Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly EBITDA year-on-year change?
- What is Chinook Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Chinook Therapeutics?
- What is Chinook Therapeutics TTM EBITDA year-on-year change?
What is Chinook Therapeutics annual EBITDA?
The current annual EBITDA of KDNY is -$168.00 M
What is the all time high annual EBITDA for Chinook Therapeutics?
Chinook Therapeutics all-time high annual EBITDA is -$46.27 M
What is Chinook Therapeutics annual EBITDA year-on-year change?
Over the past year, KDNY annual EBITDA has changed by -$93.80 M (-126.42%)
What is Chinook Therapeutics quarterly EBITDA?
The current quarterly EBITDA of KDNY is -$68.47 M
What is the all time high quarterly EBITDA for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly EBITDA is $19.39 M
What is Chinook Therapeutics quarterly EBITDA year-on-year change?
Over the past year, KDNY quarterly EBITDA has changed by -$31.07 M (-83.06%)
What is Chinook Therapeutics TTM EBITDA?
The current TTM EBITDA of KDNY is -$228.09 M
What is the all time high TTM EBITDA for Chinook Therapeutics?
Chinook Therapeutics all-time high TTM EBITDA is -$5.11 M
What is Chinook Therapeutics TTM EBITDA year-on-year change?
Over the past year, KDNY TTM EBITDA has changed by -$149.79 M (-191.31%)